Corcept Therapeutics Incorporated (CORT) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$33.1
Day's range
$34.11

Corcept Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 02/12/2026 12.06 M $419.76 M   0.12% 11.65%
VANGUARD GROUP INC 01/29/2026 9.49 M $330.42 M   -0.44% 9.17%
INGALLS & SNYDER LLC 02/13/2026 7.20 M $250.39 M   -6.53% 6.95%
RENAISSANCE TECHNOLOGIES LLC 02/12/2026 5.76 M $200.40 M   -5.43% 5.56%
PARALLEL ADVISORS, LLC 02/11/2026 3.88 M $134.99 M   0.20% 3.75%
STATE STREET CORP 02/13/2026 2.99 M $103.91 M   0.53% 2.88%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 2.67 M $92.89 M   37.98% 2.58%
FMR LLC 02/17/2026 2.41 M $84.03 M   9.66% 2.33%
UBS GROUP AG 01/29/2026 2.04 M $70.94 M   100.00% 1.97%
DIMENSIONAL FUND ADVISORS LP 02/12/2026 1.62 M $56.58 M   -14.38% 1.56%
MORGAN STANLEY 02/13/2026 1.59 M $55.40 M   34.13% 1.54%
CAPTION MANAGEMENT, LLC 02/17/2026 1.12 M $38.96 M   100.00% 1.08%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 1.06 M $36.96 M   -0.76% 1.03%
TD ASSET MANAGEMENT INC 02/10/2026 994.84 K $34.62 M   4.05% 0.96%
AQR CAPITAL MANAGEMENT LLC 02/17/2026 887.86 K $30.90 M   -41.09% 0.86%
CITADEL ADVISORS LLC 02/17/2026 863.05 K $30.03 M   673.43% 0.83%
JPMORGAN CHASE & CO 02/11/2026 834.45 K $29.04 M   -1.81% 0.81%
INVESCO LTD. 02/19/2026 817.00 K $28.43 M   11.52% 0.79%
EPOCH INVESTMENT PARTNERS, INC. 02/13/2026 816.65 K $28.42 M   -3.59% 0.79%
CERITY PARTNERS LLC 02/11/2026 755.30 K $26.28 M   -0.41% 0.73%
NORGES BANK 02/10/2026 695.77 K $24.21 M   100.00% 0.67%
FIRST TRUST ADVISORS LP 02/13/2026 693.32 K $24.13 M   -3.74% 0.67%
NORTHERN TRUST CORP 02/17/2026 629.08 K $21.89 M   -2.06% 0.61%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 624.40 K $21.73 M   230.90% 0.60%
BANK OF NEW YORK MELLON CORP 02/10/2026 581.66 K $20.24 M   -3.30% 0.56%
BOSTON TRUST WALDEN CORP 01/28/2026 527.63 K $18.36 M   -6.16% 0.51%
ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC 01/15/2026 507.97 K $19.40 M   111.82% 0.49%
CLEARBRIDGE INVESTMENTS, LLC 02/11/2026 507.35 K $17.66 M   -56.33% 0.49%
FRANKLIN RESOURCES INC 02/11/2026 468.18 K $16.29 M   -6.38% 0.45%
PRINCIPAL FINANCIAL GROUP INC 02/02/2026 444.09 K $15.45 M   -14.84% 0.43%
GOLDMAN SACHS GROUP INC 03/25/2026 430.98 K $15.00 M   10.77% 0.42%
UBS GROUP AG 01/29/2026 414.85 K $14.44 M   -24.56% 0.40%
AMERIPRISE FINANCIAL INC 02/17/2026 411.17 K $14.31 M   84.90% 0.40%
CHECKPOINT CAPITAL L.P. 02/17/2026 401.40 K $13.97 M   2.31% 0.39%
PRICE T ROWE ASSOCIATES INC /MD/ 02/17/2026 384.25 K $13.37 M   0.31% 0.37%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 345.90 K $12.04 M   72.09% 0.33%
CAPTION MANAGEMENT, LLC 02/17/2026 329.50 K $11.47 M   734.18% 0.32%
PUBLIC SECTOR PENSION INVESTMENT BOARD 02/13/2026 324.03 K $11.28 M   -11.43% 0.31%
FAS WEALTH PARTNERS, INC. 02/18/2026 310.02 K $10.79 M   0.55% 0.30%
BRIDGEWATER ASSOCIATES, LP 02/13/2026 279.00 K $9.71 M   -8.81% 0.27%
JANE STREET GROUP, LLC 02/12/2026 272.30 K $9.48 M   489.39% 0.26%
BRAUN STACEY ASSOCIATES INC 01/20/2026 264.30 K $9.20 M   -5.83% 0.26%
CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD 03/04/2026 251.63 K $8.76 M   100.00% 0.24%
ABRDN PLC 01/16/2026 245.09 K $8.53 M   -5.40% 0.24%
LEGAL & GENERAL GROUP PLC 02/09/2026 245.01 K $8.53 M   -14.57% 0.24%
IKARIAN CAPITAL, LLC 02/18/2026 236.70 K $8.24 M   100.00% 0.23%
EMERALD ADVISERS, LLC 02/09/2026 232.74 K $8.10 M   0.12% 0.22%
BURNEY CO/ 01/23/2026 223.84 K $7.79 M   -3.00% 0.22%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 02/10/2026 221.44 K $7.71 M   -40.13% 0.21%
KENNEDY CAPITAL MANAGEMENT LLC 02/13/2026 209.73 K $7.30 M   61.43% 0.20%

Corcept Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 566 institutional investors and hedge funds held shares of Corcept Therapeutics Inc. The most heavily invested institutionals were:

Parallel Advisors, LLC: 3.98 M

DIMENSIONAL FUND ADVISORS LP: 1.55 M

UBS Group AG: 1.36 M

Invesco Ltd.: 628,384

VANGUARD FIDUCIARY TRUST CO: 590,307

Bank of New York Mellon Corp: 543,757

73.96% of Corcept Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 105.17 M shares in the last 24 months. This purchase volume represents approximately $3.57 B in transactions.